Shortage Avoided

NALOXONE HCL INJECTION - 0.4MG/ML USP

SANDOZ CANADA INCORPORATED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of NALOXONE HCL INJECTION - 0.4MG/ML USP in Canada?

Not currently. The most recent shortage report for NALOXONE HCL INJECTION - 0.4MG/ML USP is marked resolved (last updated June 26, 2017).

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength0.4MG

Last updated2017-06-26

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02148706

Strength

0.4MG

Dosage Form

LIQUID

Route

INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS

Active Ingredient

NALOXONE HYDROCHLORIDE

Tier

Unrated

Last Updated

2017-06-26

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929